NEURO10-9 PHARMA INC
Biotech · Private
Polymer-based nanoparticle formulation of iduronate-2-sulfatase enzyme for subcutaneous delivery to the brain
neuronanopharma.com →- Grants
- $666K
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Nasal Leptin - Polymer Conjugate for Treatment of Obesity | $215,843 | |
| Federal grant | Department of Health and Human Services · Phase I · Nasal Leptin - Polymer Conjugate for Treatment of Obesity | $215,843 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Novel nanoparticle-based enzyme replacement therapy for Hunter Syndrome | $10,194 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Novel nanoparticle based enzyme replacement therapy for Hunter Syndrome | $223,671 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1345 | Lung Biotechnology PBC | — | — |
| 1346 | SXRNA TECHNOLOGIES, INC. | — | — |
| 1347 | Flare Therapeutics | — | — |
| 1348 | NEURO10-9 PHARMA INC | — | — |
| 1349 | OXT THERAPEUTICS, INC. | — | — |
| 1350 | COVENANT THERAPEUTICS, LLC | — | — |
| 1351 | ADVAC, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.